[PDF] Top 20 La educación ambiental como parte de los procesos de enseñanza y aprendizaje en niños a nivel inicial
Has 10000 "La educación ambiental como parte de los procesos de enseñanza y aprendizaje en niños a nivel inicial" found on our website. Below are the top 20 most common "La educación ambiental como parte de los procesos de enseñanza y aprendizaje en niños a nivel inicial".
Donepezil in Alzheimer’s disease: an evidence-based review of its impact on clinical and economic outcomes
... 1 evidence showing that donepezil has an effect in improving or limiting deterioration in behavior or mood in the short to medium term (Birks & Harvey 2003; NICE 2005; Table ...2 evidence of ... See full document
17
Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
... Abstract: Donepezil, an acetylcholinesterase inhibitor (AChEI), has been widely used to treat Alzheimer’s disease (AD) in ...of donepezil in Chinese patients. In this review, we discuss 1) the ... See full document
9
Optimal management of Alzheimer’s disease patients: Clinical guidelines and family advice
... Alzheimer’s disease (AD). Family caregivers have an important impact on clini- cal outcomes, such as quality of life ...eral clinical guidelines have been presented worldwide for ... See full document
6
Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
... Alzheimer’s disease and Related Disorders Association ...Alzheimer’s Disease Cooperative Study Activities of Daily Living Inventory modified for severe dementia (ADCS-ADLsev) and the Neuropsychiatric ... See full document
20
Thrombin use in surgery: an evidence-based review of its clinical use
... This review discusses the history, pharmacology and clinical application of thrombin as a surgical ...but its use has been complicated by the formation of antibodies that cross-react with human ... See full document
14
An evidence-based review of natalizumab therapy in the management of Crohn’s disease
... The most frequently reported adverse events with natalizumab infusion include headache, nausea, worsening of Crohn’s disease and nasopharyngitis. Other events include abdominal pain, arthralgias, fatigue, ... See full document
8
Vemurafenib: an evidence-based review of its clinical utility in the treatment of metastatic melanoma
... Despite the clinical success of vemurafenib, most, if not all, patients eventually develop resistance. Multiple resistance mechanisms have been defined and are generally grouped as either those with reactivation ... See full document
5
Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
... AD is the most common of the so-called dementias that result from the degeneration and death of cortical neurons in the brain. Prominent among the neurons that are affected early in AD are cholinergic neurons projecting ... See full document
7
Systematic review of the association between Alzheimer’s disease and chronic glaucoma
... association between dementia and glaucoma (HR, 3.90; 95% CI, 1.50–10.4). Although this study was prospective and excluded demented participants at recruitment, its short follow-up led to a small number of incident ... See full document
13
Cerebral small vessel disease and Alzheimer’s disease
... Binswanger’s disease is also known as subcortical leukoencephalopathy caused by arteriosclerosis and throm- boembolism influencing the blood vessels on the blood supply of white ... See full document
11
ALZHEIMER’S DISEASE: A REVIEW
... Building rapport with the patient, family members, and other caregivers is essential to successful management. In the early stages of AD, memory aids such as notebooks and posted daily reminders can be helpful. Common ... See full document
121
Effects on caregiver burden of a donepezil hydrochloride dosage increase to 10 mg/day in patients with Alzheimer’s disease
... taken donepezil 5 mg/day for more than 4 weeks and who agreed along with their caregivers to participate in this ...of donepezil to 10 mg/day to AD patients’ ... See full document
9
Activation of mTOR: a culprit of Alzheimer’s disease?
... This review summarizes the roles of mTOR in the patho- genesis of AD and the advancements that the upstream and downstream components of mTOR signaling are involved in a wide variety of AD ...profound ... See full document
13
Update on the use of memantine in Alzheimer’s disease
... Alzheimer’s disease (AD) have been studied in 7 random- ized controlled trials in many post-hoc ...this review, an oversight of pharma- codynamics and pharmacokinetics of memantine is ... See full document
13
Magnetic resonance spectroscopy in Alzheimer’s disease
... 6. Cheng LL, Newell K, Mallory AE, Hyman BT, Gonzalez RG. Quantification of neurons in Alzheimer and control brains with ex vivo high resolution magic angle spinning proton magnetic resonance spec- troscopy and ... See full document
6
Cerebral blood flow in Alzheimer’s disease
... Given that the sample size for each clinical group was relatively small, the nonparametric Kruskal-Wallis test was used for group comparisons. The Kruskal-Wallis test was used to discern group differences in ... See full document
9
Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer’s disease receiving donepezil
... with donepezil 5 mg/day for more than 6 ...studies based on the severity of their AD, measured using the Mini-Mental State Examination ...from donepezil to galantamine and to compare the effects of ... See full document
13
Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences
... The reasons for these disparities across studies and geo- graphic regions are not clear. Discrepancies could be due to the use of different diagnostic criteria for AD versus other forms of dementia, such as vascular ... See full document
9
Alzheimer’s disease and immunotherapy: what is wrong with clinical trials?
... features and the risk factors for onset have been examined in detail, the cause of the disease remains unclear and a radical treatment has not been developed. There has been recent focus on vaccine therapy as a ... See full document
6
The emerging role of bexarotene in the treatment of Alzheimer’s disease: current evidence
... the concern that it may be too soon to test the drug in patients with Alzheimer’s disease. On the other hand, the most impor- tant result of the 2012 study, cognitive improvement, has been independently validated. ... See full document
6
Related subjects